Treprostinil and Tenecteplase: Interaction Details

Brand names
Treprostinil
OrenitramTyvasoRemodulin +2 more
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Treprostinil

Brand names
  • Orenitram
  • Tyvaso
  • Remodulin
  • Yutrepia
  • Tyvaso DPI

Tenecteplase

We don't have a drug information page for Tenecteplase yet. Have a question about Tenecteplase? Ask a pharmacist, free →

What Happens When You Take Treprostinil With Tenecteplase

What can happen when they are taken together (rated Major)

An increased risk of bleeding

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Bleeding risk rises when tenecteplase is given together with other agents that compromise hemostasis, including antiplatelets, , and low-molecular weight heparins. Should serious bleeding occur that local pressure cannot control, any concurrent drug affecting hemostasis must be stopped right away and the patient managed appropriately.1

Because the effects are , combining an anticoagulant with a fibrinolytic (thrombolytic) agent like tenecteplase may raise the likelihood of major bleeding events.2 Two studies have shown that a thrombolytic can be coadministered safely with low-dose warfarin5 or with low-intensity warfarin therapy ( of 1.7 or less).6

Even so, when an anticoagulant must be used alongside a fibrinolytic agent, patients should be clinically monitored for signs and symptoms of external or internal bleeding, and laboratory monitoring is also recommended.3 Surgical wound drainage should be watched closely. A drop in Hb levels or a fall in blood pressure should prompt suspicion of bleeding.4

The Treprostinil and Tenecteplase Interaction, Explained

Treprostinil widens blood vessels and also makes less sticky, so it can slightly raise bleeding risk. Tenecteplase is a clot-busting medicine given in emergencies such as a heart attack or stroke, and bleeding is its main risk. Together, the chance of bleeding may be higher because both affect how your blood clots. This is a theoretical concern based on how the drugs work, not on proven cases. Tenecteplase is given in a hospital, where your team can watch you closely. If you take treprostinil, make sure the emergency team knows about it. Your care team can manage this by monitoring you and tailoring your care.

Mechanism: effects on hemostasis. Tenecteplase is a fibrinolytic (tPA analog); treprostinil is a prostacyclin analog with activity. Direction is , with increased bleeding risk. No PK change is expected, and neither agent is relevant as a here.

  • Evidence: theoretical; onset unspecified; severity on file: major.
  • Management: monitor for external and internal bleeding, and consider laboratory monitoring (Hb, coagulation tests as appropriate). Observe surgical wound drainage. Suspect bleeding if Hb or blood pressure falls.
  • For serious bleeding not controlled by local pressure, discontinue drugs that impair hemostasis immediately and treat appropriately.

See the 6 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Treprostinil and Tenecteplase Interact

The likely mechanism

effects on hemostasis

In short: Treprostinil and tenecteplase both make bleeding more likely, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Treprostinil and Tenecteplase Interaction

Tenecteplase is given in a hospital setting, so your care team can plan around this.

  • Keep taking your medicines as prescribed, and make sure the care team knows you use treprostinil.
  • Your team may monitor you more closely for signs of bleeding, and may check blood tests, including your hemoglobin.
  • If a wound or surgical site is present, staff may watch its drainage closely.
  • If bleeding occurs that does not stop with pressure, your team may stop other drugs that affect clotting and treat you right away.
  • Tell your nurse or doctor right away about unusual bleeding, black stools, dizziness, or weakness.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Treprostinil or Tenecteplase need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

3 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: ANGIOMAX IV injection, bivalirudin IV injection

    In clinical trials of patients undergoing percutaneous transluminal coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI), giving bivalirudin together with thrombolytic agents, glycoprotein IIb/IIIa , warfarin, or heparin was linked to a higher risk of major bleeding events than in patients who did not receive these medications.2 Any agent that may increase the risk of should be stopped before desirudin therapy is started.3

  2. Report 2 · Study title

    Streptokinase and concomitant oral anticoagulants in the treatment of deep venous thrombosis

    According to a Finnish study that evaluated streptokinase combined with oral for the treatment of DVT, warfarin administration caused no problems, even though lower doses were used during the streptokinase infusion. Forty-four patients first received warfarin 0.5 mg and streptokinase 600,000 international units.

    Streptokinase 600,000 international units/hour was continued for 3 days, and phlebography was performed to assess clearing of the thrombotic occlusion. If lysis was incomplete, treatment was continued for a further 3 days.

    When needed, warfarin was given to maintain the protein phosphatase (PP) activity level at 0.1 to 0.2. led to discontinuation of treatment in 8 of the 44 patients (18.2%).

    Although this study documents of oral anticoagulants and streptokinase, the anticoagulant and streptokinase were started at the same time. Because 3 to 5 days are needed before hypoprothrombinemia develops, these patients did not experience the true interaction, in which the thrombolytic effect of streptokinase occurs alongside hypoprothrombinemia resulting from warfarin use.5

  3. Report 3 · Study title

    Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin

    In a study analyzing registry data for 45,074 patients who received IV tissue plasminogen activator for acute ischemic stroke, patients on warfarin therapy with an of 1.7 or less (n=768) showed no significant increase in the risk of symptomatic intracerebral or death compared with patients not treated with warfarin (n=43,651), after adjustment for age, stroke severity, and comorbidities.6

Treprostinil and Tenecteplase: Common Questions

How serious is the Treprostinil and Tenecteplase interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Treprostinil and Tenecteplase interaction managed?

Tenecteplase is given in a hospital setting, so your care team can plan around this. Keep taking your medicines as prescribed, and make sure the care team knows you use treprostinil. Your team may monitor you more closely for signs of bleeding, and may check blood tests, including your hemoglobin. If a wound or surgical site is present, staff may watch its drainage closely. If bleeding occurs that… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Treprostinil and Tenecteplase Interaction

Ask in your own words about taking Treprostinil and Tenecteplase together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (6)

  1. Product Information: TNKase(R) intravenous injection, tenecteplase intravenous injection. Genentech Inc (per FDA), South San Francisco, CA, 2023. DailyMed
  2. Product Information: ANGIOMAX(R) IV injection, bivalirudin IV injection. The Medicines Company, Parsippany, NJ, 2005.
  3. Product Information: Iprivask(TM), desirudin for injection. Aventis Pharmaceuticals Inc. Bridgewater, NJ, 2003.
  4. Product Information: Xarelto(R) oral film-coated tablets, rivaroxaban oral film-coated tablets. Bayer HealthCare (per manufacturer), Leverkusen, Germany, 2008. DailyMed
  5. Jarvinen P, Aromaa U, Roiha M, et al: Streptokinase and concomitant oral anticoagulants in the treatment of deep venous thrombosis. Klin Wochenschr 1978; 56:801-804. PubMed
  6. Mazya MV, Lees KR, Markus R, et al: Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin. Ann Neurol 2013; 74(2):266-274. DOI
Was this write-up helpful?

Other Serious Interactions of Treprostinil and Tenecteplase

Also serious with Treprostinil

Also serious with Tenecteplase

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Treprostinil

With Tenecteplase

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.